DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» GPNMB
GPNMB
The Role of GPNMB in Inflammation
Gpnmb in Inflammatory and Metabolic Diseases
A Phase II Study of Glembatumumab Vedotin for Metastatic Uveal Melanoma
Development and Validation of a Protein-Based Risk Score for Cardiovascular Outcomes Among Patients with Stable Coronary Heart Disease
CR011, a Fully Human Monoclonal Antibody-Auristatin E Conjugate, for the Treatment of Melanoma Kam Fai Tse,1 Michael Jeffers,1 Vincent A
Biomarkers in Triple-Negative Breast Cancer: State-Of-The-Art and Future Perspectives
The Transcription Factor MITF Is a Critical Regulator of GPNMB
Preclinical PET Imaging of Glycoprotein Non-Metastatic Melanoma B in Triple Negative Breast Cancer: Feasibility of an Antibody-Based Companion Diagnostic Agent
Supplementary Material Supplementary Figure1 A. EMSA
Inhibition of Phosphatase Activity Follows Decline in Sulfatase Activity
Silencing of GPNMB by Sirna Inhibits the Formation of Melanosomes in Melanocytes in a MITF-Independent Fashion
Glycoprotein Nonmetastatic Melanoma Protein B (GPNMB) Ameliorates the Inflammatory Response in Periodontal Disease
(GPNMB) in Triple-Negative Breast Cancer
Genetics and Genomics of Parkinson's Disease
The Mitf/TFE Family of Transcription Factors: Master Regulators of Organelle Signaling, Metabolism, and Stress Adaptation Logan Slade and Thomas Pulinilkunnil
Mouse Gpnmb Knockout Project (CRISPR/Cas9)
Increased Brain Expression of GPNMB Is Associated with Genome Wide Significant Risk for Parkinson's Disease on Chromosome 7P15.3
The Role of GPNMB in Breast Cancer Progression
Top View
Glembatumumab Vedotin AACR-NCI-EORTC-2013
GPNMB/OA Protein Increases the Invasiveness of Human Metastatic Prostate Cancer Cell Lines DU145 $ and PC3 Through MMP-2 and MMP-9 Activity
Functional Domains and Evolutionary History of the PMEL and GPNMB Family Proteins
QTL Analysis of Macrophages from an AKR/Jxdba/2J Intercross Identified The
Triple Negative Breast Cancer: a Review of Present and Future Diagnostic Modalities
Genetic Dissection of the Gpnmb Network in the Eye
Microphthalmia-Associated Transcription Factor (MITF) – from Waardenburg Syndrome Genetics to Melanoma Therapy
The Tumor Suppressor FLCN Mediates an Alternate Mtor Pathway to Regulate Browning of Adipose Tissue
Glycoprotein Nmb Is Exposed on the Surface of Dormant Breast Cancer Cells and Induces Stem Cell–Like Properties
Statistical Analysis Plan
Celldex Announces Completion of Enrollment in Phase 2B Study of Glembatumumab Vedotin in Triple Negative Breast Cancer
QTL Analysis of Macrophages from an AKR/Jxdba/2J Intercross Identified the Gpnmb Gene As a Modifier of Lysosome Function
Glembatumumab Vedotin for Patients with Metastatic, Gpnmb Overexpressing, Triple-Negative Breast Cancer (“METRIC”): a Randomized Multicenter Study ✉ Linda T
Quantitative Trait Locus Mapping Identifies the Gpnmb Gene As A
Complement Activation in Peritoneal Dialysis–Induced Arteriolopathy
The Role of GPNMB on Lymphangiogenesis
Glembatumumab Vedotin (CDX-011) in Patients with Metastatic, Gpnmb
GPNMB Is Expressed in Human Epidermal Keratinocytes
Glembatumumab Vedotin, an Anti-Gpnmb Antibody-Drug Conjugate (ADC), in Combination With
CDX-011; CR011-Vcmm
DC-HIL/Gpnmb Is a Negative Regulator of Tumor Response to Immune Checkpoint Inhibitors
RNA-Sequencing Identifies Dysregulation of the Human Pancreatic Islet Transcriptome
GPNMB in Triple-Negative Breast Cancer: Elucidating Molecular Mechanisms of Action
Glycoprotein Non-Metastatic Protein B: an Emerging Biomarker for Lysosomal Dysfunction in Macrophages
DC-HIL/Gpnmb Is a Negative Regulator of Tumor Response To
GABARAP Membrane Conjugation Sequesters the FLCN-FNIP Tumor Suppressor Complex
Is GPNMB the Achilles' Heel of Mo-MDSC While Marking Their Suppressive Activity? Mario P
Phase II Trial of the Glycoprotein Non-Metastatic B-Targeted Antibody
Gpnmb/Osteoactivin: an Indicator and Therapeutic Target in Tumor and Non- Tumorous Lesions